Hims & Hers (NYSE:HIMS) stock slips as U.S. lawmakers seek FDA action against copycat versions of weight loss drugs from Novo ...

More than a third of Hims & Hers public float — over 65 million shares, or about 33.5% — are being sold short, according to data from Benzinga Pro . This level of short interest is well above average ...

Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Hims & Hers Health, Inc. (NYSE: HIMS) and certain of the Company's senior executives for ...

Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.

Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid ...

In a bid to create an affordable and accessible healthcare system in Delhi, Chief Minister Rekha Gupta on Thursday launched ...

Detailed price information for Evolent Health Inc Cl A Com (EVH-N) from The Globe and Mail including charting and trades.

Labcorp Holdings holds the No. 7 rank among its peers in the Medical-Services industry group. Hims & Hers Health HIMS, Stevanato Group STVN and Progyny PGNY are among the top 5 highly rated stocks ...

As investors have been witnessing sharp increases in speculative trading, Goldman Sachs strategists gathered the 30 U.S.

As the S&P 500 and Nasdaq Composite reach new highs, buoyed by strong corporate earnings and positive economic data, investors are keenly observing opportunities in undervalued stocks that may offer ...